Interestingly, inhibition of IL-1β using IL-1 receptor antagonist alone and deletion of IL-6 alone (in IL-6-/- mice) were not protective in a similar mouse model of cisplatin-AKI [40], suggesting that targeting multiple pathways is required for protection. This evidence concerns the gene IL1B and acute kidney injury.